Cargando…

Assessing the competitiveness of listed Chinese high-growth companies in the STAR market

This paper aims to assess the competitiveness of 68 high-growth enterprises listed on China's STAR market and explore the combination of antecedent conditions that led to their listing using fuzzy set qualitative comparative analysis. The interpretive structure model was utilized to identify th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Li, Shuo, Li, Zhiguang, Feng, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163631/ https://www.ncbi.nlm.nih.gov/pubmed/37159679 http://dx.doi.org/10.1016/j.heliyon.2023.e15735

Ejemplares similares

Value chain carbon footprints of Chinese listed companies
por: Zhang, Zengkai, et al.
Publicado: (2023)

Who monitors the monitors? An examination of listed companies in an emerging market context
por: Janse van Vuuren, Michael R., et al.
Publicado: (2022)

Who reports high company performance? A quantitative study of Chinese listed companies in the energy industry
por: Guo, Daoyan, et al.
Publicado: (2016)

Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
por: Li, Jianwei, et al.
Publicado: (2022)

Environmental regulation and financial performance of Chinese listed companies
por: Zhou, Bing, et al.
Publicado: (2020)

Is the R&D Expenditure of Listed Companies Green? Evidence from China’s A-Share Market
por: Li, Boyu, et al.
Publicado: (2022)

Chinese companies and the Hong Kong stock market /
por: Huang, Flora Xiao
Publicado: (2014)

Equity incentive contract characteristics and company operational performance—An empirical study of Chinese listed companies
por: Qiao, Mingzhe, et al.
Publicado: (2023)

Allocation of Credit Resources and “Borrow to Lend” Activities: Evidence From Chinese-Listed Companies
por: Zhao, Shangmei, et al.
Publicado: (2022)

Does Chinese-style margin trading promote the high-quality development of listed companies?
por: Tang, Jingyao, et al.
Publicado: (2023)

The Impact of Government Official Assessment on Ecological Poverty Alleviation: Evidence from Chinese Listed Companies
por: Huang, Yujing
Publicado: (2022)

Expected vs. real growth of companies listed on the London Stock Exchange
por: Pietraszewski, Piotr, et al.
Publicado: (2023)

Celebrity CEOs and firm innovation investment: Evidence from Chinese-listed companies
por: Shao, Dong, et al.
Publicado: (2022)

Dialect diversity and total factor productivity: Evidence from Chinese listed companies
por: Xiong, Jiacai, et al.
Publicado: (2022)

The application of structural and machine learning models to predict the default risk of listed companies in the Iranian capital market
por: Peykani, Pejman, et al.
Publicado: (2023)

Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets
por: Baranes, Edmond, et al.
Publicado: (2015)

Does COVID-19 make the firms’ performance worse? Evidence from the Chinese listed companies()
por: Zhang, Dongyang, et al.
Publicado: (2022)

Central environmental inspection and corporate environmental investment: evidence from Chinese listed companies
por: Wang, Junshui, et al.
Publicado: (2022)

Share repurchase and the cost of capital: Discussion on the nature of share repurchase of Chinese listed companies
por: Wang, Ping, et al.
Publicado: (2023)

Does venture capital Quan Zi affect stock mispricing: Evidence from Chinese listed companies
por: Chen, Ping, et al.
Publicado: (2023)

Does Overseas Investment Raise Corporate Environmental Protection? Evidence from Chinese A-List Companies
por: Wang, Quan-Jing, et al.
Publicado: (2022)

Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies
por: Chen, Yixiao, et al.
Publicado: (2023)

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

Competitive Market Analysis of Transplant Centers and Discrepancy of Wait-Listing of Recipients for Kidney Transplantation
por: Cho, P. S., et al.
Publicado: (2015)

Economic Policy Uncertainty and Family Firm Innovation: Evidence From Listed Companies in China
por: Qi, Yong, et al.
Publicado: (2022)

Multifractal Company Market: An Application to the Stock Market Indices
por: Chorowski, Michał, et al.
Publicado: (2022)

Can fund shareholding inhibit insufficient R&D input?——Empirical evidence from Chinese listed companies
por: Li, Xiao, et al.
Publicado: (2021)

Do Tournament Incentives Matter for CEOs to Be Environmentally Responsible? Evidence from Chinese Listed Companies
por: Ullah, Sajid, et al.
Publicado: (2022)

CEO turnover and corporate innovation: What can we learn from Chinese listed companies
por: Sun, Shujun, et al.
Publicado: (2022)

Performance evaluation and analysis of Chinese insurance companies under uncertain financial markets
por: Jia-Ying, Jiang, et al.
Publicado: (2023)

The incentive role of media companies’ executive compensation system in transformation and upgrading: Evidence from listed media companies in China
por: Yang, Wancheng, et al.
Publicado: (2023)

Financial Crisis Warning for Listed Manufacturing Companies in China
por: Wang, Yang, et al.
Publicado: (2022)

Digital Transformation and Financial Risk Prediction of Listed Companies
por: Xinxian, Chen, et al.
Publicado: (2022)

Do environmental, social, and governance scores improve green innovation? Empirical evidence from Chinese-listed companies
por: Zhang, Chunlian, et al.
Publicado: (2023)

Financial crisis early warning of Chinese listed companies based on MD&A text-linguistic feature indicators
por: Zhang, Zhishuo, et al.
Publicado: (2023)

Research on the Effect of Executive Incentive Institutional Innovation on the Cost of Equity—Evidence From Chinese Listed Companies
por: Wang, Jin, et al.
Publicado: (2021)

Will executive equity incentives affect investor relations management: Empirical evidence from Chinese listed companies
por: Shi, Xiaofei, et al.
Publicado: (2022)

Networking capital as a tool for competitiveness in companies.
por: Parra Salmerón, Sergio Ignacio
Publicado: (2023)

Corruption perception, institutional quality and performance of listed companies in Nigeria
por: Ojeka, Stephen, et al.
Publicado: (2019)

Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies
por: López-Toro, Alberto A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v2dft2pmmj31g0kn8pd642ffq0